SEC Form 4 · accession 0001683168-26-007396
Valion Bio, Inc. · VBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lisa G Wolf
Officer — COO & CFO
Period of report
Sep 18, 2026
Accepted (ET)
Sep 24, 2026 · 4:45 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001787740
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F3 | Sep 18, 2026 | M | 4 | — | A | 29 | D | |
| Common StockF4 | Sep 18, 2026 | F | 2 | $2.12 | D | 27 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF4,F1,F3 | — | Sep 18, 2026 | M | 4 | D | — | — | Common Stock | 4 | 19 | D |
Explanation of responses
- F1Each Restricted Stock Unit is convertible into one share of Common Stock.
- F2The Reporting Person forfeited 2 shares of Common Stock upon vesting and settlement of 4 outstanding Restricted Stock Units to cover tax withholdings, using the market price of the Issuer's Common Stock at the time of forfeiture.
- F3Fifty percent (50%) of the Restricted Stock Units vested upon the one (1) year anniversary of the date of grant, December 18, 2024 (the "Vesting Commencement Date"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date.
- F4These numbers have been adjusted to reflect the reverse stock split of the Common Stock of Valion Bio, Inc., which underwent a reverse stock split at a ratio of 1-for-25 on August 31, 2026.